Work

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas

Year: 2018

Type: article

Source: Nature Medicine

DOI: 10.1038/s41591-018-0006-x

Authors: Christopher W. Mount, Robbie G. Majzner, Shree Sundaresh, Evan P. Arnold, Meena Kadapakkam, Samuel Haile, Louai Labanieh, Esther Hulleman, Pamelyn J. Woo, Skyler P. Rietberg, Hannes Vogel, Michelle Monje, Crystal L. Mackall

Institutions: Stanford Medicine, Stanford University, Amsterdam UMC Location Vrije Universiteit Amsterdam, Stanford Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Association for Cancer Research, Alex's Lemonade Stand Foundation for Childhood Cancer, Virginia and D.K. Ludwig Fund for Cancer Research, Children's Hospital Los Angeles, Cure Starts Now Foundation, Parker Institute for Cancer Immunotherapy, Stand Up To Cancer, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G147635816, G4089804188, Neuroligin 3 in oligodendrocyte development

OpenAlex ID: W2803040262

FWCI: 15.41

Cites: 51

Cited by: 502

Related to: 10